Abstract
The lethal(3)malignant brain tumor (D-l(3)mbt) gene is considered to be one of the tumor suppressor genes of Drosophila, and its recessive mutations are associated with malignant transformation of the neuroblasts in the larval brain. The structure of D-l(3)mbt protein is similar to Drosophila sex comb on midleg (Scm) protein which is a member of Polycomb group (PcG) proteins. We have isolated here the first human homolog of the D-l(3)mbt gene, designated h-l(3)mbt. Radiation hybrid mapping and fluorescence in situ hybridization (FISH) analysis localized the h-l(3)mbt gene to chromosome 20q12. The h-l(3)mbt transcript is expressed in most of the human adult normal tissues and cultured cell lines. However, some cancer cells markedly reduce the h-l(3)mbt protein expression. Immunocytochemical study revealed that the h-l(3)mbt protein shows a speckled and scattered distribution in interphase nuclei and completely associates with condensed chromosomes in mitotic cells. This subcellular localization has been shown to be different from that of Bmi1 protein which is a component of PcG complex. Furthermore, overexpression of h-l(3)mbt protein by using a Cre-mediated gene activation system leads to failures of proper chromosome segregation and cytokinesis, which result in formation of multinuclei in U251MG cells. These observations suggest that h-l(3)mbt protein has functions distinct from those of PcG proteins and may play a role in proper progression of cell division.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF, Kerlavage AR, McCombie WT and Venter JC. . 1991 Science 252: 1651–1656.
Akasaka T, Kanno M, Balling R, Mieza MA, Taniguchi M and Koseki H. . 1996 Development 122: 1513–1522.
Alkema MJ, Bronk M, Verhoeven E, Otte A, van't Veer LJ, Berns A and van Lohuizen M. . 1997a Genes Dev. 11: 226–240.
Alkema MJ, Jacobs J, Voncken JW, Jenkins NA, Copeland NG, Satijn DP, Otte AP, Berns A and van Lohuizen M. . 1997b J. Mol. Biol. 273: 993–1003.
Alkema MJ, van der Lugt NM, Bobeldijk RC, Berns A and van Lohuizen M. . 1995 Nature 374: 724–727.
Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ. . 1990 J. Mol. Biol. 215: 403–410.
Bornemann D, Miller E and Simon J. . 1996 Development 122: 1621–1630.
Buchenau P, Hodgson J, Strutt H and Arndt-Jovin DJ. . 1998 J. Cell. Biol. 141: 469–481.
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M. . 1987 Proc. Natl. Acad. Sci. USA 84: 7413–7417.
Gateff E, Loffler T and Wismar J. . 1993 Mech. Dev. 41: 15–31.
Gateff E and Mechler BM. . 1989 Crit. Rev. Oncog. 1: 221–245.
Gatti M and Baker BS. . 1989 Genes Dev. 3: 438–453.
Guan XY, Xu J, Anzick SL, Zhang H, Trent JM and Meltzer PS. . 1996 Cancer Res. 56: 3446–3450.
Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, Hu X, Colbert AME, Rosenberg C, Reeve-Daly MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Ganiatsas S, Evans CA, DeAngelis MM, Ingalls KA, Nahf RW, Horton Jr LT, Anderson MO, Collymore AJ, Ye W, Kouyoumjian V, Zemsteva IS, Tam J, Devine R, Courtney DF, Renaud MT, Nguygen H, O'Connor TJ, Fizames C, Faure S, Gyapay G, Dib C, Morissette J, Orlin JB, Birren BW, Goodman N, Weissenback J, Hawkins TL, Foote S, Page DC and Lander ES. . 1995 Science 270: 1945–1954.
Jin DY, Spencer F and Jeang KT. . 1998 Cell 93: 81–91.
Jones CA, Ng J, Peterson AJ, Morgan K, Simon J and Jones RS. . 1998 Mol. Cell. Biol. 18: 2825–2834.
Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S and Saito I. . 1995 Nucl. Acids Res. 23: 3816–3821.
Kanegae Y, Takamori K, Sato Y, Lee G, Nakai M and Saito I. . 1996 Gene 181: 207–212.
Kellum R, Raff JW and Albets BM. . 1995 J. Cell Sci. 108: 1407–1418.
Kodjabachian L, Delaage M, Maurel C, Miassod R, Jacq B and Rosset R. . 1998 EMBO J. 17: 1063–1075.
Makino K, Kuwahara H, Masuko N, Nishiyama Y, Morisaki T, Sasaki J, Nakao M, Kuwano A, Nakata M, Ushio Y and Saya H. . 1997 Oncogene 14: 2425–2433.
Muller J. . 1995 EMBO J. 14: 1209–1220.
Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y and Saya H. . 1998 Oncogene 16: 1009–1019.
Pak DT, Pflumm M, Chesnokov I, Huang DW, Kellum R, Marr J, Romanowski P and Botchan MR. . 1997 Cell 91: 311–323.
Pirrotta V. . 1997a Trends Genet. 13: 314–318.
Pirrotta V. . 1997b Curr. Opin. Genet. Dev. 7: 249–258.
Sewalt RG, van der Vlag J, Gunster MJ, Hamer KM, den Blaauwen JL, Satijn DP, Hendrix T, van Driel R and Otte AP. . 1998 Mol. Cell. Biol. 18: 3586–3595.
Simon J. . 1995 Curr. Opin. Cell. Biol. 7: 376–385.
Takeshima H, Izawa I, Lee PS, Safdar N, Levin VA and Saya H. . 1994 Oncogene 9: 2135–2144.
Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P and Kallioniemi OP. . 1996 Cancer Res. 56: 3441–3445.
Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S and Otsu M. . 1998 EMBO J. 17: 667–676.
van der Lugt NM, Alkema M, Berns A and Deschamps J. . 1996 Mech. Dev. 58: 153–164.
van Lohuizen M. . 1998 Cell. Mol. Life Sci. 54: 71–79.
van Lohuizen M, Tijms M, Voncken JW, Schumacher A, Magnuson T and Wientjens E. . 1998 Mol. Cell. Biol. 18: 3572–3579.
Watson KL, Justice RW and Bryant PJ. . 1994 J. Cell. Sci. Suppl. 18: 19–33.
Wismar J, Loffler T, Habtemichael N, Vef O, Geissen M, Zirwes R, Altmeyer W, Saas H and Gateff E. . 1995 Mech. Dev. 53: 141–154.
Yamamoto Y, Girard F, Bello B, Affolter M and Gehring WJ. . 1997 Development 124: 3385–3394.
Acknowledgements
We thank Drs A Kikuchi (Department of Biochemi., Hiroshima University), and H Maruta (Ludwig Institute for Cancer Research) for providing the pBJ-Myc and the pGEX-2TH plasmids, respectively; Dr M von Lohuizen (Department of Molecular Carcinogenesis, The Netherlands Cancer Institute) for providing F6 anti-Bmi1 monoclonal antibody; Drs I Saitoh and Y Kanegae (Laboratory of Molecular Genetics, Institute of Medical Science, the University of Tokyo) for providing the Cre-loxP gene activation system; Dr T Kishimoto (Biomedical R&D Department, Sumitomo Electric Industries) for assistance in antibody production: Dr K Akagi (Saitama Cancer Center) for valuable discussion; and T Arino for secretarial assistance. This work was supported by a grant for Cancer Research from the Ministry of Education, Science and Culture of Japan (Hideyuki Saya).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koga, H., Matsui, Si., Hirota, T. et al. A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes. Oncogene 18, 3799–3809 (1999). https://doi.org/10.1038/sj.onc.1202732
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202732
Keywords
This article is cited by
-
Mitotic bookmarking by transcription factors
Epigenetics & Chromatin (2013)
-
Epigenetic regulation: methylation of histone and non-histone proteins
Science in China Series C: Life Sciences (2009)
-
Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
Leukemia (2008)
-
Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1
Oncogene (2008)
-
Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions
Annals of Hematology (2008)